Gene therapy reality check: there’s a big pipeline, but few drugs are close to approval https://t.co/Xcr6k7xvgI
— The Propell Group (@ThePropellGroup) October 18, 2016
#healthtech
Gene therapy reality check: there’s a big pipeline, but few drugs are close to approval https://t.co/Xcr6k7xvgI
— The Propell Group (@ThePropellGroup) October 18, 2016
#healthtech